Spero Therapeutics Announces Presentations at IDWeek 2019
26 sept. 2019 08h30 HE
|
Spero Therapeutics, Inc.
CAMBRIDGE, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and...